It may require different treatment approaches than standard telogen effluvium management, and resources covering peptides for hormone balance and peptide support during perimenopause may provide additional context
Avoid GLP-1s if you have a multiple endocrine neoplasia syndrome type 2 (MEN2)
Furthermore, these drugs are not a panacea for the obesity epidemic, as comprehensive solutions must also address underlying behavioral, social, and environmental factors
Understanding GLP-1s and their dynamic marketplace and workplace trends [Unpublished] With the availability of newer treatment options for weight management glucagon-like peptide 1 (GLP-1) medications metabolic health is in the news, shining a light for the public on the impact of weight on overall health
Safety Considerations and Side Effects Like all medications, GLP-1 drugs have potential side effects: Common side effects include: Nausea, vomiting, diarrhea (usually improving over time) Constipation Stomach pain or indigestion Injection site reactions (mild redness or itching) Less common but more serious concerns include: Pancreatitis (inflammation of the pancreas) Kidney problems Gastroparesis (stomach paralysis) in rare cases Joint and bone issues like arthritis and tendinitis Researchers found no established link between GLP-1 medications and pancreatitis, pancreatic cancer, or thyroid cancer in large studies with years of follow-up
